Unum Group (UNM) stock
UNMNYSEAccident & Health InsuranceFiscal year ends December 31Also trades as UNMA
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 12/3010% below fair value
$76.95−1.73 (-2.20%)
Close on Nov 17, 2026Market cap $12.31BP/E 17.9Yield 2.29%
Unum EPS
Diluted earnings per share is net income divided by the share count including options and convertible securities.
Unum's EPS for the twelve months ending Jun 30, 2026 was $4.29, down 48.7% year over year. For fiscal 2025 it was $4.27, down 54.9% from the year before. Over ten years it grew 2.0% a year on average. The highest annual figure on record is $9.46 in fiscal 2024.
Annual eps
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $4.27 | -54.9% |
| FY2024 | Dec 31, 2024 | $9.46 | +45.5% |
| FY2023 | Dec 31, 2023 | $6.50 | -6.6% |
| FY2022 | Dec 31, 2022 | $6.96 | +45.3% |
| FY2021 | Dec 31, 2021 | $4.79 | +23.1% |
| FY2020 | Dec 31, 2020 | $3.89 | -25.8% |
| FY2019 | Dec 31, 2019 | $5.24 | +120.2% |
| FY2018 | Dec 31, 2018 | $2.38 | -45.5% |
| FY2017 | Dec 31, 2017 | $4.37 | +10.6% |
| FY2016 | Dec 31, 2016 | $3.95 | +12.9% |
| FY2015 | Dec 31, 2015 | $3.50 | +122.9% |
| FY2014 | Dec 31, 2014 | $1.57 | -50.8% |
| FY2013 | Dec 31, 2013 | $3.19 | +0.6% |
| FY2012 | Dec 31, 2012 | $3.17 | +237.2% |
| FY2011 | Dec 31, 2011 | $0.94 | -65.1% |
| FY2010 | Dec 31, 2010 | $2.69 | +4.7% |
| FY2009 | Dec 31, 2009 | $2.57 | +58.6% |
| FY2008 | Dec 31, 2008 | $1.62 | -15.2% |
| FY2007 | Dec 31, 2007 | $1.91 | – |
Quarterly eps
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $1.61 | -16.1% |
| Q1 FY2026 | Mar 31, 2026 | $1.41 | +33.0% |
| Q4 FY2025 | Dec 31, 2025 | $1.04 | -45.8% |
| Q3 FY2025 | Sep 30, 2025 | $0.23 | -93.4% |
| Q2 FY2025 | Jun 30, 2025 | $1.92 | -6.3% |
| Q1 FY2025 | Mar 31, 2025 | $1.06 | -48.0% |
| Q4 FY2024 | Dec 31, 2024 | $1.92 | +13.6% |
| Q3 FY2024 | Sep 30, 2024 | $3.46 | +239.2% |
| Q2 FY2024 | Jun 30, 2024 | $2.05 | +3.5% |
| Q1 FY2024 | Mar 31, 2024 | $2.04 | +13.3% |
| Q4 FY2023 | Dec 31, 2023 | $1.69 | +17.4% |
| Q3 FY2023 | Sep 30, 2023 | $1.02 | -59.7% |
| Q2 FY2023 | Jun 30, 2023 | $1.98 | +9.4% |
| Q1 FY2023 | Mar 31, 2023 | $1.80 | +52.5% |
| Q4 FY2022 | Dec 31, 2022 | $1.44 | -7.1% |
| Q3 FY2022 | Sep 30, 2022 | $2.53 | +58.1% |
| Q2 FY2022 | Jun 30, 2022 | $1.81 | +103.4% |
| Q1 FY2022 | Mar 31, 2022 | $1.18 | +57.3% |
| Q4 FY2021 | Dec 31, 2021 | $1.55 | +134.8% |
| Q3 FY2021 | Sep 30, 2021 | $1.60 | +41.6% |
| Q2 FY2021 | Jun 30, 2021 | $0.89 | -31.5% |
| Q1 FY2021 | Mar 31, 2021 | $0.75 | -5.1% |
| Q4 FY2020 | Dec 31, 2020 | $0.66 | -54.2% |
| Q3 FY2020 | Sep 30, 2020 | $1.13 | -2.6% |
| Q2 FY2020 | Jun 30, 2020 | $1.30 | -2.3% |
| Q1 FY2020 | Mar 31, 2020 | $0.79 | -39.7% |
| Q4 FY2019 | Dec 31, 2019 | $1.44 | +25.2% |
| Q3 FY2019 | Sep 30, 2019 | $1.16 | – |
| Q2 FY2019 | Jun 30, 2019 | $1.33 | +3.1% |
| Q1 FY2019 | Mar 31, 2019 | $1.31 | +6.5% |
| Q4 FY2018 | Dec 31, 2018 | $1.15 | -3.4% |
| Q3 FY2018 | Sep 30, 2018 | -$1.30 | -216.1% |
| Q2 FY2018 | Jun 30, 2018 | $1.29 | +20.6% |
| Q1 FY2018 | Mar 31, 2018 | $1.23 | +23.0% |
| Q4 FY2017 | Dec 31, 2017 | $1.19 | +11.2% |
| Q3 FY2017 | Sep 30, 2017 | $1.12 | +10.9% |
| Q2 FY2017 | Jun 30, 2017 | $1.07 | – |
| Q1 FY2017 | Mar 31, 2017 | $1.00 | – |
| Q4 FY2016 | Dec 31, 2016 | $1.07 | – |
| Q3 FY2016 | Sep 30, 2016 | $1.01 | – |
- Revenue
- Gross Profit
- Operating Income
- Net Income
- EBITDA
- Free Cash Flow
- Operating Cash Flow
- R&D Expenses
- Gross Margin
- Operating Margin
- Profit Margin
- Total Debt
- Cash
- Total Assets
- Shares Outstanding
- Market Cap
- Enterprise Value
- PE Ratio
- Price to Sales Ratio
- Price to Book Ratio
- EV/EBITDA
- Price to Free Cash Flow
- All statistics
See a number that looks wrong?